About Katie Grace Carpenter Katie Grace Carpenter is a science writer and curriculum developer, with degrees in biology and biogeochemistry
In clinical trials, GLP-1 receptor agonists have demonstrated substantial and clinically meaningful weight loss
Several mechanisms are thought to contribute, and these should be understood as hypotheses based on the drug's pharmacology and observations from related incretin-based therapies: Reduced caloric intake: Retatrutide significantly suppresses appetite, often leading to a substantial reduction in food consumption
Stopping semaglutide often leads to weight regain, so some people may take it indefinitely
Ozempic is actually a brand name for semaglutide , a medication that helps with weight loss and managing type 2 diabetes
For diabetes (Victoza), the maximum dose is lower at 1.8mg daily, with a similar but shorter titration